Increased electronegative LDL and decreased antibodies against electronegative LDL levels correlate with inflammatory markers and adhesion molecules in hemodialysed patients

Clinica Chimica Acta

Volumn 412, Issue 19-20, 2011, Pages 1788-1792

  Lobo, Julie Calixto ^a   Mafra, Denise ^b   Farage, Najla Elias ^c   Faulin, Tanize do Espirito Santo ^d   Abdalla, Dulcineia Saes Parra ^d   de Nóbrega, Antonio Claudio Lucas ^b   Torres, João Paulo Machado ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c Renalcor Clinic   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoantibodies; Electronegative LDL; Hemodialysis; Inflammation

Indexed keywords

AUTOANTIBODY; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN ANTIBODY; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 79960645980     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.05.034     Document Type: Article

References (34)

1. Avogaro P., Bittolo-Bon G., Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988, 8:79-87.
2. Sánchez-Quesada J.L., Benítez S., Ordóñez-Llanos J. Electronegative low-density lipoprotein. Curr Opin Lipidol 2004, 15:329-335.
3. Benitez S., Camacho M., Bancells C., et al. Wide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein array. Biochim Biophys Acta 2006, 1761:1014-1021.
4. Benítez S., Bancells C., Ordonez-Llanos J., Sanchez-Quesada J.L. Pro-inflammatory action of LDL(-) on mononuclear cells is counteracted by increased IL10 production. Biochim Biophys Acta 2007, 1771:613-622.
5. Chen H.H., Hosken B.D., Huang M., et al. Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic. J Lipid Res 2007, 48:177-184.
6. Tai M.H., Kuo S.M., Liang H.T., et al. Modulation of angiogenic processes in cultured endothelial cells by low density lipoproteins subfractions from patients with familial hypercholesterolemia. Atherosclerosis 2006, 186:448-457.
7. Sanchez-Quesada J.L., Benitez S., Franco M., Blanco-Vaca F., Ordonez-Llanos J. Density distribution of electronegative LDL [LDL(-)] in normolipemic and hyperlipemic subjects. J Lipid Res 2002, 43:699-705.
8. Sanchez-Quesada J.L., Perez A., Caixas A., et al. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification. J Clin Endocrinol Metab 2001, 86:3243-3249.
9. Sanchez-Quesada J.L., Bernitez S., Perez A., et al. The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity. Diabetologia 2005, 48:2162-2169.
10. Yano M., Inoue M., Maehata E. Increased electronegative charge of serum low-density lipoprotein in patients with diabetes mellitus. Clin Chim Acta 2004, 340:93-98.
11. Gambino R., Pisu E., Pagano G., Cassader M. Low-density lipoproteins are more electronegatively charged in type 1 than in type 2 diabetes mellitus. Lipids 2006, 41:529-533.
12. Yang C.Y., Chen H.H., Huang M.T. Pro-apoptotic low-density lipoprotein subfractions in type II diabetes. Atherosclerosis 2007, 193:283-291.
13. Ziouzenkova O., Asatryan L., Akmal M. Oxidative crosslinking of apob100 and hemoglobin results in low density lipoprotein modification in blood relevance to atherogenesis caused by hemodialysis. J Biol Chem 1999, 274:18916-18924.
14. Lobo J., Santos F., Grosso D. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal. Nephron Clin Pract 2008, 108(4):298-304.
15. De Caterina A.R., Leone A.M. Why beta-blockers should not be used as first choice in uncomplicated hypertension. Am J Cardiol 2010, 105(10):1433-1438. 15.
16. Keys A., Fidanza F., Karvonen M.J., Kimura N., Taylor H.L. Indices of relative weight and obesity. J Chronic Dis 1972, 25:329-343.
17. Faulin T.E.S., Sena K.C.M., Telles A.E.R., Grosso D.M., Faulin E.J.B., Abdalla D.S.P. Validation of a novel ELISA for measurement of electronegative low-density lipoprotein. Clin Chem Lab Med 2008, 46(12):1769-1775.
18. Bernitez S., Ordonez-Llanos J., Franco M., et al. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor. Am J Cardiol 2004, 93:414-420.
19. De Castellarnau C., Bancells C., Benitez S., et al. Atherogenic and inflammatory profile of human arterial endothelial cells (HUAEC) in response to LDL subfractions. Clin Chim Acta 2007, 376:233-236.
20. Zhang B., Miura S., Yanagi D., et al. Reduction of charge-modified LDL by statin therapy in patients with CHD or CHD risk factors and elevated LDL-C levels: the SPECIAL Study. Atherosclerosis 2008, 201(2):353-359.
21. Yang C.Y., Raya J.L., Chen H.H., et al. Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins. Arterioscler Thromb Vasc Biol 2003, 23:1083-1090.
22. De Castellarnau C., Sanchez-Quesada J.L., Benitez S., et al. Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells. Arterioscler Thromb Vasc Biol 2000, 20:2281-2287.
23. Sanchez-Quesada J.L., Camacho M., Anton R., et al. Electronegative LDL of FH subjects: chemical characterization and induction of chemokine release from human endothelial cells. Atherosclerosis 2003, 166:261-270.
24. Abe Y., Fornage M., Yang C.Y., et al. L5, the most electronegative subfraction of plasma LDL, induces endothelial vascular cell adhesion molecule 1 and CXC chemokines, which mediate mononuclear leukocyte adhesion. Atherosclerosis 2007, 192:56-66.
25. Cachofeiro V., Goicochea M., de Vinuesa S.G., et al. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 2008, 74:4-9.
26. Morgan M.J., Liu Z.G. Reactive oxygen species in TNFα-induced signaling and cell death. Mol Cells 2010, 30:1-12.
27. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000, 101:2149-2153.
28. Skoog T., Dichtl W., Boquist S., et al. Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J 2002, 23:376-383.
29. Barros M.R., Bertolami M.C., Abdalla D.S., Ferreira W.P. Identification of mildly oxidized low-density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic offsprings. Atherosclerosis 2006, 184:103-107.
30. Shoji T., Fukumoto M., Kimoto E., et al. Antibody to oxidized lowdensity lipoprotein and cardiovascular mortality in end-stage renal disease. Kidney Int 2002, 62:2230-2237.
31. Shoji T., Kimoto E., Emoto M., et al. The association of antibodies against oxidized low density lipoprotein with atherosclerosis in hemodialysis patients. Kidney Int 2003, 84(suppl):128-130.
32. Karvonen J., Paivansalo M., Kesaniemi Y.A., Horkko S. Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 2003, 108:2107-2112.
33. Grosso D.M., Ferderbar S., Wanschel A.C.B.A., Krieger M.H., Higushi M.L., Abdalla D.S.P. Antibodies against electronegative LDL inhibit atherosclerosis in LDLr-/- mice. Braz J Med Biol Res 2008, 41:1086-1109.
34. Shoenfeld Y., Wu R., Dearing L.D., Matsuura E. Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?. Circulation 2004, 110:2552-2558.